NCT00315848View on ClinicalTrials.gov

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

PHASE3CompletedINTERVENTIONAL

Enrollment

225

Participants

Timeline

Start Date

November 30, 1996

Study Completion Date

December 31, 1999

Conditions

Osteoarthritis

Interventions

DRUG

Buprenorphine transdermal delivery system

Trial Locations (10)

12208

Stratton VA Medical Center, Albany

32605

Gainesville Clinical Research Center, Gainesville

33324

Park Place Therapeutic Center, Plantation

35801

Rheumatology Associates of North Alabama, Huntsville

47714

MediSphere Medical Research Center, L.L.C., Evansville

75235

Metroplex Clinical Research Center, Dallas

78240

Arthritis Diagnostic and Treatment Center, San Antonio

80030

Western Integrated Pain Treatment Centers, Westminster

85012

Arizona Research and Education, Phoenix

85015

Phoenix Center for Clinical Research, Phoenix

All Listed Sponsors

lead

Purdue Pharma LP

INDUSTRY

NCT00315848 - The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain. | Biotech Hunter | Biotech Hunter